Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “lung cancer”

A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and AtezolizumabActive Not Recruiting
NCT05142696Phase 1, Phase 2Updated Aug 19, 2026
Sponsor: Novartis Pharmaceuticals
Extensive Stage Small Cell Lung Cancer
United States, Austria, Canada, China, Czechia +7 more
To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR MutationsActive Not Recruiting
NCT06194448Phase 2Updated Aug 19, 2026
Sponsor: AstraZeneca
Lung Cancer
United States, China, Israel, South Korea, Spain +4 more
A Nurse-Led Intervention for Fear of Progression in Advanced CancerActive Not Recruiting
NCT04819997NAUpdated Aug 19, 2026
Sponsor: City of Hope Medical Center
Advanced Lung Carcinoma · Metastatic Malignant Female Reproductive System Neoplasm · Stage III Lung Cancer AJCC v8 · Stage IIIA Lung Cancer AJCC v8
United States
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerRecruiting
NCT04181060Phase 3Updated Aug 19, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Lung Non-Squamous Non-Small Cell Carcinoma · Metastatic Lung Non-Squamous Non-Small Cell Carcinoma · Recurrent Lung Non-Squamous Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8
United States
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsRecruiting
NCT07115043Phase 1, Phase 2Updated Aug 19, 2026
Sponsor: AstraZeneca
Melanoma · Non-small Cell Lung Cancer · Squamous Cell Carcinoma (Skin) · Renal Cell Carcinoma
United States, Australia, Japan, South Korea
A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2Recruiting
NCT07203053Phase 2Updated Aug 19, 2026
Sponsor: ETOP IBCSG Partners Foundation
Extensive Stage Lung Small Cell Cancer
France, Greece, Italy, Spain, Switzerland
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid TumorsRecruiting
NCT07636785Phase 1, Phase 2Updated Aug 19, 2026
Sponsor: VM Discovery, Inc.
Hepatocellular Carcinoma (HCC) · Metastatic Uveal Melanoma · Renal Cell Carcinoma (RCC) · Nonsmall Cell Lung Cancer
United States
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility StudyRecruiting
NCT04949464NAUpdated Aug 19, 2026
Sponsor: AIDS Malignancy Consortium
HIV Infection · Tobacco-Related Carcinoma
United States
Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal DiseaseActive Not Recruiting
NCT03025256Phase 1Updated Aug 19, 2026
Sponsor: M.D. Anderson Cancer Center
Acral Lentiginous Melanoma · Central Nervous System Melanoma · Clinical Stage IV Cutaneous Melanoma AJCC v8 · Leptomeningeal Neoplasm
United States
Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene AbnormalitiesRecruiting
NCT04683250Phase 1, Phase 2Updated Aug 19, 2026
Sponsor: Taiho Pharmaceutical Co., Ltd.
RET-altered Non Small Cell Lung Cancer · RET-altered Solid Tumors
United States, Australia, Japan, South Korea
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene AmplificationsTerminated
NCT05827614Phase 1Updated Aug 19, 2026
Sponsor: Boundless Bio, Inc.
Triple Negative Breast Cancer (TNBC) · High Grade Serous Ovarian Carcinoma · High Grade Endometrial Carcinoma · Anogenital Cancer
United States
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung CancerActive Not Recruiting
NCT04092283Phase 3Updated Aug 19, 2026
Sponsor: National Cancer Institute (NCI)
Recurrent Lung Non-Small Cell Carcinoma · Stage III Lung Cancer AJCC v8 · Stage IIIA Lung Cancer AJCC v8 · Stage IIIB Lung Cancer AJCC v8
United States, Guam
ASKC202 Combined With Limertinib Versus Platinum-based Chemotherapy in Treatment of Locally Advanced or Metastatic NSCLC With MET Amplification/Overexpression After Failure of EGFR-TKI TherapyRecruiting
NCT07109531Phase 3Updated Aug 19, 2026
Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Locally Advanced or Metastatic NSCLC
China
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyRecruiting
NCT07472517Phase 3Updated Aug 19, 2026
Sponsor: Boehringer Ingelheim
Small Cell Lung Cancer (SCLC) · Extensive-stage Small Cell Lung Cancer (ES-SCLC)
United States, Argentina, Australia, Austria, Belgium +37 more
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid MalignanciesActive Not Recruiting
NCT04644068Phase 1, Phase 2Updated Aug 19, 2026
Sponsor: AstraZeneca
Ovarian Cancer · Breast Cancer · Pancreatic Cancer · Prostate Cancer
United States, Australia, Canada, China, Czechia +9 more
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.Recruiting
NCT07365319Phase 2, Phase 3Updated Aug 19, 2026
Sponsor: Eikon Therapeutics
Non Small Cell Lung Cancer (Squamous or Non Squamous) · Stage 4 NSCLC
United States, Australia, Spain
Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLCRecruiting
NCT07246863Phase 2Updated Aug 19, 2026
Sponsor: CatalYm GmbH
Metastatic Non-Squamous Non-Small Cell Lung Cancer · Adult Solid Tumor
United States, Germany, Italy, Poland, Romania +2 more
Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer PatientsActive Not Recruiting
NCT04310020Phase 2Updated Aug 19, 2026
Sponsor: National Cancer Institute (NCI)
Lung Non-Small Cell Carcinoma · Stage II Lung Cancer AJCC v8 · Stage III Lung Cancer AJCC v8
United States
Pemefolacianine for IMI of Lung CancerRecruiting
NCT07772895Phase 1Updated Aug 19, 2026
Sponsor: Sunil Singhal
Lung Cancer (Locally Advanced or Metastatic)
United States
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for CancerRecruiting
NCT05787834NAUpdated Aug 19, 2026
Sponsor: Roswell Park Cancer Institute
Breast Carcinoma · Head and Neck Cancer · Lung Cancer
United States
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationActive Not Recruiting
NCT07023731Phase 1, Phase 2Updated Aug 19, 2026
Sponsor: Arvinas Inc.
KRAS G12D Mutation · Advanced Solid Cancer
United States
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasRecruiting
NCT04104776Phase 1, Phase 2Updated Aug 19, 2026
Sponsor: Novartis Pharmaceuticals
Advanced Solid Tumor · Diffuse Large B Cell Lymphoma · Lymphoma, T-Cell · Mesothelioma, Malignant
United States, France, Italy, Poland, South Korea +2 more
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid TumorsRecruiting
NCT06120283Phase 1Updated Aug 19, 2026
Sponsor: BeOne Medicines
Advanced Solid Tumor · Advanced Breast Cancer · Metastatic Breast Cancer · Hormone-receptor-positive Breast Cancer
United States, Australia, Brazil, China, France +6 more
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine CancersNot Yet Recruiting
NCT07707895Phase 1, Phase 2Updated Aug 19, 2026
Sponsor: Boehringer Ingelheim
Small Cell Lung Cancer · Large Cell Neuroendocrine Lung Carcinoma · Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology · Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology
United States, Australia, Belgium, China, France +6 more
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Recruiting
NCT06452277Phase 3Updated Aug 19, 2026
Sponsor: Bayer
Advanced Non-small Cell Lung Cancer, HER2 Mutation
United States, Argentina, Australia, Austria, Belgium +31 more

Previous page Next page